With the decision n. 261/2021 of the 10th September 2021, the Administrative court of Friuli Venezia Giulia has ruled on relevant aspects related to the compulsory vaccination for healthcare personnel established by art. 4 D.L. 44/2021. The court has clarified that it is incorrect to claim that the vaccines used in the current vaccine campaign are still on trial, since they have been authorized by the Commission with a conditional marketing authorization, after EMA recommendation.
Con sentenza del 10 settembre 2021 n. 261/2021, il Tar Friuli Venezia Giulia ha avuto modo di pronunciarsi su alcuni aspetti rivelanti legati all’obbligo vaccinale per il personale sanitario, previsto dall’art. 4 D.L. 44/2021 e di chiarire che è errato sostenere che i vaccini attualmente utilizzati nella campagna vaccinale contro il virus Sars-Cov2 siano sperimentali, essendo stati autorizzati dalla Commissione, previa raccomandazione dell’EMA, attraverso la c.d. procedura di autorizzazione condizionata (CMA – conditional marketing authorization).
Il Tar Friuli Venezia Giulia si pronuncia sull’obbligo vaccinale per i sanitari: i vaccini non sono sperimentali = The administrative court of Friuli Venezia Giulia rules on the compulsory vaccination for the healthcare personnel: vaccines used against Covid are not experimental / G. RE FERRE'. - In: CERIDAP. - ISSN 2723-9195. - 2021:4(2021 Oct 06), pp. 165-169. [10.13130/2723-9195/2021-4-4]
Il Tar Friuli Venezia Giulia si pronuncia sull’obbligo vaccinale per i sanitari: i vaccini non sono sperimentali = The administrative court of Friuli Venezia Giulia rules on the compulsory vaccination for the healthcare personnel: vaccines used against Covid are not experimental
G. RE FERRE'
2021
Abstract
With the decision n. 261/2021 of the 10th September 2021, the Administrative court of Friuli Venezia Giulia has ruled on relevant aspects related to the compulsory vaccination for healthcare personnel established by art. 4 D.L. 44/2021. The court has clarified that it is incorrect to claim that the vaccines used in the current vaccine campaign are still on trial, since they have been authorized by the Commission with a conditional marketing authorization, after EMA recommendation.| File | Dimensione | Formato | |
|---|---|---|---|
|
Ceridap_Re Ferrè_Estratto-10.13130_2723-9195_2021-4-4.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
215.54 kB
Formato
Adobe PDF
|
215.54 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.




